IRIS
CASTELLI, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.987
AS - Asia 2.151
SA - Sud America 1.533
EU - Europa 759
Continente sconosciuto - Info sul continente non disponibili 115
AF - Africa 92
OC - Oceania 4
Totale 8.641
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.801
BR - Brasile 1.351
SG - Singapore 947
CN - Cina 376
IT - Italia 315
VN - Vietnam 275
HK - Hong Kong 221
FR - Francia 97
AR - Argentina 78
DE - Germania 69
MX - Messico 63
GB - Regno Unito 52
FI - Finlandia 49
CA - Canada 46
IN - India 42
TR - Turchia 40
BD - Bangladesh 32
IQ - Iraq 30
RU - Federazione Russa 29
ZA - Sudafrica 29
EC - Ecuador 27
JP - Giappone 27
CO - Colombia 26
ID - Indonesia 21
SE - Svezia 21
UA - Ucraina 21
UZ - Uzbekistan 21
MA - Marocco 20
PL - Polonia 18
VE - Venezuela 16
ES - Italia 15
AT - Austria 14
JO - Giordania 14
PK - Pakistan 12
PY - Paraguay 12
AZ - Azerbaigian 11
HN - Honduras 11
JM - Giamaica 11
KE - Kenya 10
CL - Cile 9
CZ - Repubblica Ceca 9
AE - Emirati Arabi Uniti 8
DO - Repubblica Dominicana 8
DZ - Algeria 8
NL - Olanda 8
NP - Nepal 8
CR - Costa Rica 7
PH - Filippine 7
PR - Porto Rico 7
RS - Serbia 7
SV - El Salvador 7
TN - Tunisia 7
TT - Trinidad e Tobago 7
IL - Israele 6
KR - Corea 6
KZ - Kazakistan 6
NI - Nicaragua 6
SA - Arabia Saudita 6
UY - Uruguay 6
EG - Egitto 5
LB - Libano 5
LT - Lituania 5
AL - Albania 4
AU - Australia 4
GE - Georgia 4
PE - Perù 4
AM - Armenia 3
BE - Belgio 3
BO - Bolivia 3
CH - Svizzera 3
CI - Costa d'Avorio 3
GT - Guatemala 3
IE - Irlanda 3
KG - Kirghizistan 3
MY - Malesia 3
PA - Panama 3
SN - Senegal 3
BB - Barbados 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
CY - Cipro 2
EE - Estonia 2
GP - Guadalupe 2
HU - Ungheria 2
IR - Iran 2
KW - Kuwait 2
OM - Oman 2
RO - Romania 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BS - Bahamas 1
BZ - Belize 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
ET - Etiopia 1
GA - Gabon 1
GY - Guiana 1
HR - Croazia 1
Totale 8.511
Salva come PNG Salva come JPEG
Città #
Dallas 1.356
Singapore 496
San Jose 369
Ashburn 264
Chandler 229
Council Bluffs 219
Hong Kong 216
Santa Clara 154
Princeton 138
Beijing 109
Ho Chi Minh City 100
Columbus 99
New York 90
São Paulo 88
Lauterbourg 80
Milan 75
Shanghai 46
Rio de Janeiro 45
Hanoi 43
Los Angeles 43
Belo Horizonte 34
Helsinki 33
Brasília 30
Tokyo 27
Curitiba 22
Miano 22
Da Nang 21
Orem 21
Atlanta 18
Munich 18
Warsaw 17
Sassari 16
Tashkent 16
Baghdad 15
Goiânia 15
Stockholm 15
Campinas 14
Johannesburg 14
Mexico City 14
Porto Alegre 14
Ribeirão Preto 14
Amman 13
Chennai 13
Denver 13
Frankfurt am Main 13
Guarulhos 13
Montreal 13
Nuremberg 13
Phoenix 13
Brooklyn 12
Falkenstein 12
Fortaleza 12
Haiphong 12
Rome 12
Santo André 12
São José dos Campos 12
The Dalles 12
Duque de Caxias 11
Poplar 11
Baku 10
Nairobi 10
Sorocaba 10
Tianjin 10
Düsseldorf 9
Franca 9
London 9
Quito 9
Turku 9
Bogotá 8
Boston 8
Cagliari 8
Campo Grande 8
Cape Town 8
Chicago 8
Dhaka 8
Houston 8
Joinville 8
Petrópolis 8
Recife 8
Seattle 8
Shenzhen 8
Vienna 8
Amsterdam 7
Ankara 7
Asunción 7
Betim 7
Brno 7
Casablanca 7
Guayaquil 7
Istanbul 7
Juiz de Fora 7
Maceió 7
Manaus 7
Manchester 7
Medellín 7
Olbia 7
Querétaro 7
San Francisco 7
San Salvador 7
São Gonçalo 7
Totale 5.214
Salva come PNG Salva come JPEG
Nome #
Impact of recombinant erythropoietin on anemia, physical function, and cognitive assessment in hospitalized older adults 393
Acquired Hemophilia A after SARS-CoV-2 Immunization: A Narrative Review of a Rare Side Effect 236
Case Report: Dangerous liaisons between splenectomy and eltrombopag-induced chronic thromboembolic pulmonary hypertension in patients with immune thrombocytopenia: report of two cases and review of the literature 196
A Diagnostic of Acquired Hemophilia Following PD1/PDL1 Inhibitors in Advanced Melanoma: The Experience of Two Patients and a Literature Review 176
ADAMTS13, von Willebrand Factor, Platelet Microparticles, Factor VIII, and Impact of Somatic Mutations in the Pathogenesis of Splanchnic Vein Thrombosis Associated with BCR-ABL-Negative Myeloproliferative Neoplasms 166
Brachial Tunneled Peripherally Inserted Central Catheters and the Risk of Catheter Complications: A Systematic Review and Meta-Analysis 157
Aging of the Arterial System 154
Angioedema due to acquired C1-inhibitor deficiency : a bridging condition between autoimmunity and lymphoproliferation 142
Cancer and thromboembolism: from biology to clinics 140
Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants 137
Common Variable Immunodeficiency and Selective IgA Deficiency: Focus on Autoimmune Manifestations and Their Pathogenesis 132
Acquired deficiency of the inhibitor of the first complement component: presentation, diagnosis, course, and conventional management 131
Biosimilar epoetin alfa increases haemoglobin levels and brings cognitive and socio-relational benefits to elderly transfusion-dependent multiple myeloma patients: results from a pilot study 128
Bendamustine and Rituximab, as First Line Treatment, in Intermediate, High Risk Splenic Marginal Zone Lymphomas of Elderly Patients 127
Sodium–Glucose Cotransporter-2 Inhibitors After Acute Myocardial Infarction 124
Abnormal Hemostatic Parameters and Risk of Thromboembolism Among Patients With COVID-19 Infection 122
Aggressive natural killer cell leukaemia with a complex karyotype: a case report 119
Choosing treatment options for patients with relapsed/refractory multiple myeloma 118
Biosimilar epoetin in elderly patients with low risk myelodisplastic syndromes improves anaemia, quality of life and brain function 117
The Janus faces of acquired angioedema: C1-inhibitor deficiency, lymphoproliferation and autoimmunity 117
Acquired C1-inhibitor deficiency and lymphoproliferative disorders : a tight relationship 116
Current and Emerging Treatment Options for Patients with Relapsed Myeloma 109
Immunomodulatory drugs : new options for the treatment of myelodysplastic syndromes 108
Incidence of Venous Thromboembolism in Multiple Myeloma Patients across Different Regimens: Role of Procoagulant Microparticles and Cytokine Release 108
Bendamustine in association with rituximab for first-line treatment of diffuse large B-cell lymphoma in frail patients ineligible for R-CHOP/R-CHOP-like treatments 106
Aggressive natural killer cell leukaemia with a complex karyotype: a case report 105
Prothrombotic and inflammatory markers in elderly patients with non-alcoholic hepatic liver disease before and after weight loss: A pilot study 104
Ferric Carboxymaltose and Erythropoiesis-Stimulating Agent Treatment Reduces the Rate of Blood Transfusion in Refractory Anemia 101
Anti-t-PA antibodies in acute myocardial infarction after thrombolysis with rt-PA 101
Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH Clinical Practice Guideline Update 100
The heparins and cancer: review of clinical trials and biological properties 99
Endocrine Side Effects in Patients Treated with Immune Checkpoint Inhibitors: A Narrative Review 96
Therapeutic options for patients with angioedema due to C1-inhibitor deficiencies : from pathophysiology to the clinic 96
Midline peripheral catheters inserted in the superficial femoral vein at mid-thigh: Wise choice in COVID-19 acute hypoxemic respiratory failure patients with helmet continuous positive airway pressure 96
Mutational profile of ZBTB16-RARA-positive acute myeloid leukemia 95
Splenic marginal zone lymphomas in acquired C1-inhibitor deficiency : clinical and molecular characterization 94
First-line treatment with bendamustine and rituximab, in patients with intermediate-/high-risk splenic marginal zone lymphomas 92
Complement Activation in Patients With Immune Thrombocytopenic Purpura According to Phases of Disease Course 90
Inflammatory and prothrombotic parameters in normotensive non-diabetic obese women : effect of weight loss obtained by gastric banding 90
Effect of hydroxyurea on extramedullary haematopoiesis in thalassaemia intermedia : case reports and literature review 90
Neutrophilic progression in a case of polycytemia vera mimicking chronic neutrophilic leukemia: clinical and molecular characterization 90
Management of anaemia in onco-haematological patients treated with biosimilar epoetin alfa: results of an Italian observational, retrospective study 90
Does Outcome/Survival of Patients With Myelodysplastic Syndromes Should Be Predicted by Reduced Levels of ADAMTS-13? Results From a Pilot Study 89
The impact of an aging population on the diagnosis of pulmonary embolism: comparison of young and elderly patients 89
Possible Effect of Polycystic Ovary Syndrome (PCOS) on Cardiovascular Disease (CVD): An Update 86
Successful management with intravenous immunoglobulins in alemtuzumab-induced acute inflammatory demyelinating neuropathy : clinical report of three patients 85
Sodium-Glucose Cotransporter-2 Inhibitors in Diabetic Patients with Heart Failure: An Update 84
Platelet Microvesicles, Inflammation, and Coagulation Markers: A Pilot Study 84
Clinical Characteristics and treatment outcome of an 86-year old patient with acute myeloid leukemia with acute promyelocytic - like morphology and uncommon RARA fusion variant 84
High prevalence of heparin induced thrombocytopenia with thrombosis among patients with essential thrombocytemia carrying V617F mutation 84
Salvage therapy with bortezomib and dexamethasone in elderly patients with relapsed/refractory multiple myeloma 83
Interaction of C1 inhibitor with thrombin on the endothelial surface 83
The value of four-detector row spiral computed tomography for the diagnosis of pulmonary embolism 82
Risk Of Thrombosis In Elderly Immune Primary Trombocytopenic Patients Treated With Thrombopoietin Receptors Agonists 82
Immunomodulatory drugs in multiple myeloma : from molecular mechanisms of action to clinical practice 81
High prevalence of splenic marginal zone lymphoma among patients with acquired C1 inhibtor deficiency 81
Thromboembolic complications in malignant haematological disorders 81
Heparin induced thrombocytopenia: pathogenetic, clinical, diagnostic and therapeutic aspects 81
Transmission of hepatitis G virus in patients with angioedema treated with steam-heated plasma concentrates of C1 inhibitor 81
Discrepancies between bone marrow histopathology and clinical phenotype in BCR-ABL1-negative myeloproliferative neoplasms associated with splanchnic vein thrombosis 80
Concomitant use of Tyrosine-Kinase Inhibitor and Mepolizumab in Asthma Secondary to Chronic Myeloid Leukemia with Hypereosinophilia 78
Rheumatoid factors : clinical applications 78
Hiv-Related Lymphoprolipherative Diseases In The Era Of Combination Antiretroviral Therapy 78
Ibrutinib related bleeding complications in elderly patients with B cell malignancies 77
Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical praticeguidelineupdate 76
Thrombosis and hemostatic Abnormalities in haematological malignancies 76
Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients 76
Unusual severe development of common B lymphoblastic leukemia in Gaucher disease type I 75
Massive Right Atrial Thrombosis: Are You Brave Enough to Start Anticoagulation? A Case Report 73
The impact of anaemia, transfusion dependency, commorbidities and polypharmacy in elderly patients with low-risk myelodysplastic syndromes 73
Syncope in patients with pulmonary embolism: comparison between patients with syncope as the presenting symptom of pulmonary embolism and patients with pulmonary embolism without syncope 73
Integrated short peripheral intravenous cannulas and risk of catheter failure: A systematic review and meta-analysis 72
Intrathoracic masses due to extramedullary hematopoiesis 70
Reduction in transmission of hepatitis C after the introduction of a heat-treatment step in the production of C1-inhibitor concentrate 69
Eltrombopag treatment for thrombocytopenia in myelodysplastic syndromes: differences between responding and non-responding patients—a pilot study 67
High rate of hepatitis B viral breakthrough in elderly non-Hodgkin lymphomas patients treated with Rituximab based chemotherapy 67
Increased risk of heparin induced thrombocytopenia and thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation 65
Lymphoproliferative disease and acquired C1 inhibitor deficiency 63
Personalized treatment strategies for elderly patients with myelodysplastic syndromes 63
New antithrobotic agents 61
Managment of anemia in low risk myelodysplastic syndromes treated with erythropoiesis-stimulating agents newer and older agents 59
Pulmonary embolism in elderly patients: prognostic impact of the Cumulative Illness Rating Scale (CIRS) on short-term mortality 58
Eltrombopag reduces bleeding complications and the need of platelet transfusions in cirrhotic thrombocytopenic patients subjected to invasive procedures 57
Laboratory and clinical risk assessment to treat myelodysplatic syndromes 53
Unreliable estimation of HbA due to the presence of Camperdown haemoglobin [beta 104 (G6) Arg --> Ser] 52
Risk-tailored treatment of splenic marginal zone lymphoma 52
null 45
High Rate of hepatitis B viral breakthrought in elderly non Hodgkin lymphomas patients treated with Rituximab based chemotherapy 27
Totale 8.641
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.126
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.126
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022200 0 0 0 0 0 0 83 0 3 4 21 89
2022/2023515 69 0 2 85 50 77 0 85 96 8 25 18
2023/2024213 26 22 5 3 8 57 2 10 0 6 17 57
2024/20252.370 10 13 84 24 104 81 169 631 800 294 69 91
2025/20264.151 153 950 831 797 321 175 400 112 121 165 89 37
2026/20271.192 88 292 322 490 0 0 0 0 0 0 0 0
Totale 8.641